Skip to main content
Erschienen in: Pediatric Surgery International 2/2010

01.02.2010 | Original Article

Immunohistological evidence for Wnt-signaling activation in Peutz-Jeghers polyposis

verfasst von: Walawee Chaiyapan, Surasak Sangkhathat, Samornmas Kanngurn, Monlika Phukaoloun, Piyawan Chiengkriwate, Sakda Patrapinyokul

Erschienen in: Pediatric Surgery International | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

Molecular pathogenesis of gastrointestinal polyposis in Peutz-Jegher’s syndrome (PJS) has been linked to the loss-of-function mutation of LKB1. Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway and activation of the pathway as a consequence of LKB1 haploinsufficiency might be responsible for the development of harmatomatous polyps. This study aimed to look for immunohistochemical evidence of Wnt-signaling activation in PJS polyps.

Method

Beta-catenin immunohistochemistry patterns were evaluated in gastrointestinal polyps from five cases of PJS. All patients were also evaluated for germline mutations of LKB1 and somatic mutations of beta-catenin in the polyps.

Results

Four of the five cases had germline mutations of LKB1, including two novel mutations, a one-base insertion at codon 53 and a large deletion encompassing exon 3 (codon 136–155). PJS polyps from all patients showed generalized membrane and cytoplasmic localizations of beta-catenin along the mucosal endothelium. Polyps from two cases with LKB1 mutations revealed moderate-intensity nuclear staining in approximately 20 and 70% of the polyps.

Conclusion

The study offers additional evidence of Wnt-signaling activation in PJS polyp development at the tissue level, although the degree of up-regulation was not as high as has been found in Wnt-associated neoplasms.
Literatur
1.
Zurück zum Zitat Giardiello FM, Trimbath JD (2006) Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 4:408–415CrossRefPubMed Giardiello FM, Trimbath JD (2006) Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 4:408–415CrossRefPubMed
2.
Zurück zum Zitat Giardiello FM, Welsh SB, Hamilton SR et al (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316:1511–1514PubMedCrossRef Giardiello FM, Welsh SB, Hamilton SR et al (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316:1511–1514PubMedCrossRef
3.
Zurück zum Zitat Hemminki A, Tomlinson I, Markie D et al (1997) Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 15:87–90CrossRefPubMed Hemminki A, Tomlinson I, Markie D et al (1997) Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 15:87–90CrossRefPubMed
4.
Zurück zum Zitat Jenne DE, Reimann H, Nezu J et al (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38–43CrossRefPubMed Jenne DE, Reimann H, Nezu J et al (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38–43CrossRefPubMed
5.
Zurück zum Zitat Hemminki A, Markie D, Tomlinson I et al (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184–187CrossRefPubMed Hemminki A, Markie D, Tomlinson I et al (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184–187CrossRefPubMed
6.
Zurück zum Zitat Westerman AM, Entius MM, Boor PP et al (1999) Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat 13:476–481CrossRefPubMed Westerman AM, Entius MM, Boor PP et al (1999) Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat 13:476–481CrossRefPubMed
7.
Zurück zum Zitat Yoon KA, Ku JL, Choi HS et al (2000) Germline mutations of the STK11 gene in Korean Peutz-Jeghers syndrome patients. Br J Cancer 82:1403–1406PubMed Yoon KA, Ku JL, Choi HS et al (2000) Germline mutations of the STK11 gene in Korean Peutz-Jeghers syndrome patients. Br J Cancer 82:1403–1406PubMed
8.
Zurück zum Zitat McGarrity TJ, Amos C (2006) Peutz-Jeghers syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci 63:2135–2144CrossRefPubMed McGarrity TJ, Amos C (2006) Peutz-Jeghers syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci 63:2135–2144CrossRefPubMed
9.
Zurück zum Zitat Miyaki M, Iijima T, Hosono K et al (2000) Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome. Cancer Res 60:6311–6313PubMed Miyaki M, Iijima T, Hosono K et al (2000) Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome. Cancer Res 60:6311–6313PubMed
10.
Zurück zum Zitat Lin-Marq N, Borel C, Antonarakis SE (2005) Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling. Mol Genet Genomics 273:184–196CrossRefPubMed Lin-Marq N, Borel C, Antonarakis SE (2005) Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling. Mol Genet Genomics 273:184–196CrossRefPubMed
11.
Zurück zum Zitat Wanitsuwan W, Kanngurn S, Boonpipattanapong T, Sangthong R, Sangkhathat S (2008) Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers. World J Gastroenterol 14:6052–6059CrossRefPubMed Wanitsuwan W, Kanngurn S, Boonpipattanapong T, Sangthong R, Sangkhathat S (2008) Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers. World J Gastroenterol 14:6052–6059CrossRefPubMed
12.
Zurück zum Zitat Sangkhathat S, Kusafuka T, Miao J et al (2006) In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors. Int J Oncol 28:715–722PubMed Sangkhathat S, Kusafuka T, Miao J et al (2006) In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors. Int J Oncol 28:715–722PubMed
13.
Zurück zum Zitat Thakur N, Reddy DN, Rao GV, Mohankrishna P, Singh L, Chandak GR (2006) A novel mutation in STK11 gene is associated with Peutz-Jeghers Syndrome in Indian patients. BMC Med Genet 7:73CrossRefPubMed Thakur N, Reddy DN, Rao GV, Mohankrishna P, Singh L, Chandak GR (2006) A novel mutation in STK11 gene is associated with Peutz-Jeghers Syndrome in Indian patients. BMC Med Genet 7:73CrossRefPubMed
14.
Zurück zum Zitat Wang ZJ, Churchman M, Campbell IG et al (1999) Tomlinson IPM. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumors. Br J Cancer 80:70–72CrossRefPubMed Wang ZJ, Churchman M, Campbell IG et al (1999) Tomlinson IPM. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumors. Br J Cancer 80:70–72CrossRefPubMed
15.
Zurück zum Zitat Amos CI, Keitheri-Cheteri MB, Sabripour M et al (2004) Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet 41:327–333CrossRefPubMed Amos CI, Keitheri-Cheteri MB, Sabripour M et al (2004) Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet 41:327–333CrossRefPubMed
16.
Zurück zum Zitat Olschwang S, Boisson C, Thomas G (2001) Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J Med Genet 38:356–360CrossRefPubMed Olschwang S, Boisson C, Thomas G (2001) Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J Med Genet 38:356–360CrossRefPubMed
17.
Zurück zum Zitat Katajisto P, Vallenius T, Vaahtomeri K et al (2007) The LKB1 tumor suppressor kinase in human disease. Biochem Biophys Acta 1775:63–75PubMed Katajisto P, Vallenius T, Vaahtomeri K et al (2007) The LKB1 tumor suppressor kinase in human disease. Biochem Biophys Acta 1775:63–75PubMed
18.
Zurück zum Zitat Aretz S, Stienen D, Uhlhaas S et al (2005) High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat 26:513–519CrossRefPubMed Aretz S, Stienen D, Uhlhaas S et al (2005) High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat 26:513–519CrossRefPubMed
19.
Zurück zum Zitat Iwamoto M, Hoffenberg EJ, Carethers JM et al (2005) Nuclear accumulation of beta-catenin occurs commonly in the epithelial cells of juvenile polyps. Pediatr Res 57:4–9CrossRefPubMed Iwamoto M, Hoffenberg EJ, Carethers JM et al (2005) Nuclear accumulation of beta-catenin occurs commonly in the epithelial cells of juvenile polyps. Pediatr Res 57:4–9CrossRefPubMed
20.
Zurück zum Zitat Coffin CM, Hornick JL, Zhou H, Fletcher CD (2007) Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Am J Surg Pathol 31:410–416CrossRefPubMed Coffin CM, Hornick JL, Zhou H, Fletcher CD (2007) Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Am J Surg Pathol 31:410–416CrossRefPubMed
21.
Zurück zum Zitat Wu JM, Montgomery EA, Iacobuzio-Donahue CA (2008) Frequent beta-catenin nuclear labeling in sessile serrated polyps of the colorectum with neoplastic potential. Am J Clin Pathol 129:416–423CrossRefPubMed Wu JM, Montgomery EA, Iacobuzio-Donahue CA (2008) Frequent beta-catenin nuclear labeling in sessile serrated polyps of the colorectum with neoplastic potential. Am J Clin Pathol 129:416–423CrossRefPubMed
22.
Zurück zum Zitat Spicer J, Rayter S, Young N, Elliott R, Ashworth A, Smith D (2003) Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1. Oncogene 22:4752–4756CrossRefPubMed Spicer J, Rayter S, Young N, Elliott R, Ashworth A, Smith D (2003) Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1. Oncogene 22:4752–4756CrossRefPubMed
23.
Zurück zum Zitat Back W, Loff S, Jenne D, Bleyl U (1999) Immunolocalization of beta catenin in intestinal polyps of Peutz-Jeghers and juvenile polyposis syndromes. J Clin Pathol 52:345–349CrossRefPubMed Back W, Loff S, Jenne D, Bleyl U (1999) Immunolocalization of beta catenin in intestinal polyps of Peutz-Jeghers and juvenile polyposis syndromes. J Clin Pathol 52:345–349CrossRefPubMed
Metadaten
Titel
Immunohistological evidence for Wnt-signaling activation in Peutz-Jeghers polyposis
verfasst von
Walawee Chaiyapan
Surasak Sangkhathat
Samornmas Kanngurn
Monlika Phukaoloun
Piyawan Chiengkriwate
Sakda Patrapinyokul
Publikationsdatum
01.02.2010
Verlag
Springer-Verlag
Erschienen in
Pediatric Surgery International / Ausgabe 2/2010
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-009-2547-z

Weitere Artikel der Ausgabe 2/2010

Pediatric Surgery International 2/2010 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.